Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sulfonamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118638123A reveals high-purity chiral organic phase change crystals. Discover cost-effective manufacturing and scalable supply chain solutions for new energy applications.
Advanced synthesis of bioactive piperidine sulfonamide compounds via patent CN107151248A. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102365272B reveals a safer bromination method for Rosuvastatin intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel patent CN101343244A details efficient sulfonamide synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN108727283B reveals a novel three-step Pd-catalyzed route for high-purity benzenesulfonamide intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN108727283A reveals high-yield quinazoline synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108976178A reveals a safe, atmospheric Pd-catalyzed route for chiral sulfonamides. Discover cost-effective manufacturing and supply chain advantages.
Novel route for anticancer intermediates via chalcone cyclization. Enhances purity and scalability for pharmaceutical manufacturing supply chains.
Patent CN108473418A reveals a safer chiral resolution method for sulfonamide derivatives. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN118978462A reveals a green N-S coupling method. It offers high yield and selectivity for sulfonamide derivatives, ensuring cost reduction and supply reliability.
Advanced synthesis of N-[4-(3-benzyl-ureidomethyl)-2,5-diethoxyphenyl]methanesulfonamide via nickel-catalyzed reduction for high-purity pharmaceutical intermediate supply chains.
Patent CN105820071A details a stable Type II diabetes intermediate synthesis. Offers cost reduction and reliable supply chain for pharmaceutical manufacturing partners globally.
Patent CN116574038A reveals a green Cu-catalyzed route for N-aryl sulfonamides using ethanol. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN117945956B enables mild synthesis of N-trifluoromethyl sulfonamides, offering supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing.
Advanced synthesis of 3-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide via patent CN113773270A. Offers high purity, reduced steps, and reliable supply chain for global pharmaceutical manufacturers.
Patent CN112898318A enables high-purity chiral polycyclic synthesis. Reduces heavy metal risks and improves supply chain reliability for pharma intermediates.
Patent CN110938084A details a novel NHC-catalyzed route for chiral indolosulfonamides, offering high enantioselectivity and streamlined supply chain solutions for pharmaceutical intermediates.
Patented N-[2,5-diethoxy-4-(3-p-tolyl-ureidomethyl)-phenyl]-methanesulfonamide route. High yield intermediate for Type II diabetes drug development.
Patent CN111548291B details a green synthesis for N-phenyl-N-trichloromethylthio benzenesulfonamide. Achieve high purity and reduced wastewater for rubber processing safety.
Patent CN111039829B details a safe continuous flow method for producing p-acetamidobenzenesulfonyl chloride, offering high purity and reduced waste for pharmaceutical intermediates.